Blue light therapy delivered through light glasses improves sleep quality and daytime sleepiness in Parkinson's disease: A randomized trial.
Katarzyna Śmiłowska, Nienke M de Vries, Bastiaan R Bloem et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial evaluated the effects of blue light therapy delivered through glasses on sleep quality and daytime sleepiness in individuals with Parkinson's disease. The study found significant improvements in sleep quality, with Pittsburgh Sleep Quality Index scores showing a large effect size of 0.896 at five weeks (p = 0.029). Additionally, excessive daytime sleepiness decreased from 50.0% to 6.7% (p = 0.005).
Key findings
- Significant improvement in Pittsburgh Sleep Quality Index scores with blue light therapy (p = 0.021).
- Sleep quality significantly improved at five weeks compared to placebo (p = 0.029) with a large effect size (0.896).
- Excessive daytime sleepiness reduced from 50.0% to 6.7% in the blue light group (p = 0.005).
Why it matters
Sleep disturbances are prevalent in Parkinson's disease and can severely impact quality of life. This study suggests that blue light therapy may provide an effective, convenient alternative to traditional light therapy, potentially improving patient outcomes.